+

CA2368152A1 - Nouvelles techniques permettant de traiter et de diagnostiquer le cancer du sein, compositions et techniques de criblage pour modulateurs de cancer du sein - Google Patents

Nouvelles techniques permettant de traiter et de diagnostiquer le cancer du sein, compositions et techniques de criblage pour modulateurs de cancer du sein Download PDF

Info

Publication number
CA2368152A1
CA2368152A1 CA002368152A CA2368152A CA2368152A1 CA 2368152 A1 CA2368152 A1 CA 2368152A1 CA 002368152 A CA002368152 A CA 002368152A CA 2368152 A CA2368152 A CA 2368152A CA 2368152 A1 CA2368152 A1 CA 2368152A1
Authority
CA
Canada
Prior art keywords
breast cancer
protein
expression
antibody
bch1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002368152A
Other languages
English (en)
Inventor
David Mack
Kurt C. Gish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EOS Biotechnology Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2368152A1 publication Critical patent/CA2368152A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des techniques utilisées pour diagnostiquer et pronostiquer le cancer du sein. L'invention concerne également des techniques pouvant être utilisées pour cribler des agents bioactifs candidats, permettant de moduler le cancer du sein. L'invention concerne, en outre, des techniques et des cibles moléculaires (gènes et leurs produits) permettant d'intervenir thérapeutiquement dans le cancer du sein et dans d'autres cancers.
CA002368152A 1999-03-15 2000-03-15 Nouvelles techniques permettant de traiter et de diagnostiquer le cancer du sein, compositions et techniques de criblage pour modulateurs de cancer du sein Abandoned CA2368152A1 (fr)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
USUNKNOWN 1998-04-08
US26886599A 1999-03-15 1999-03-15
US09/268,865 1999-03-15
US44037099A 1999-11-12 1999-11-12
US43987899A 1999-11-12 1999-11-12
US09/439,878 1999-11-12
US09/440,370 1999-11-12
US44049399A 1999-11-15 1999-11-15
US09/440,493 1999-11-15
US44067699A 1999-11-16 1999-11-16
US44067799A 1999-11-16 1999-11-16
US09/440,677 1999-11-16
US09/440,676 1999-11-16
US45081099A 1999-11-29 1999-11-29
US09/450,810 1999-11-29
US45313799A 1999-12-02 1999-12-02
US09/453,137 1999-12-02
PCT/US2000/006952 WO2000055629A2 (fr) 1999-03-15 2000-03-15 Nouvelles techniques permettant de traiter et de diagnostiquer le cancer du sein, compositions et techniques de criblage pour modulateurs de cancer du sein

Publications (1)

Publication Number Publication Date
CA2368152A1 true CA2368152A1 (fr) 2000-09-21

Family

ID=27575318

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002368152A Abandoned CA2368152A1 (fr) 1999-03-15 2000-03-15 Nouvelles techniques permettant de traiter et de diagnostiquer le cancer du sein, compositions et techniques de criblage pour modulateurs de cancer du sein

Country Status (4)

Country Link
EP (1) EP1159619A2 (fr)
AU (1) AU3752700A (fr)
CA (1) CA2368152A1 (fr)
WO (1) WO2000055629A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE413466T1 (de) 1998-09-02 2008-11-15 Diadexus Inc Verfahren zur diagnose, bewertung sowie bilddarstellung verschiedener krebserkrankungen
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6468546B1 (en) 1998-12-17 2002-10-22 Corixa Corporation Compositions and methods for therapy and diagnosis of ovarian cancer
US7888477B2 (en) 1998-12-17 2011-02-15 Corixa Corporation Ovarian cancer-associated antibodies and kits
US6962980B2 (en) 1999-09-24 2005-11-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
AU1777201A (en) * 1999-11-16 2001-05-30 Eos Biotechnology, Inc. Novel methods of diagnosing and determining prognosis of breast cancer, compositions, and methods of screening for breast cancer modulators
WO2001037779A2 (fr) * 1999-11-23 2001-05-31 Diadexus, Inc. Nouvelle methode de diagnostic, de surveillance, de stadification, d'imagerie et de traitement du cancer du sein
US7238471B1 (en) 1999-11-23 2007-07-03 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating breast cancer
US7285382B2 (en) 2000-01-25 2007-10-23 Genentech, Inc. Compositions and methods for treatment of cancer
US7534417B2 (en) 2000-02-24 2009-05-19 Agensys, Inc. 103P2D6: tissue specific protein highly expressed in various cancers
GB0004576D0 (en) * 2000-02-25 2000-04-19 Oxford Glycosciences Uk Ltd Proteins
AU2001245953A1 (en) * 2000-03-24 2001-10-08 Genzyme Corporation Oncogenic osteomalacia-related gene 1
JP2004500852A (ja) * 2000-05-19 2004-01-15 エフ．　ホフマン−ラ　ロシュ　アーゲー ヒト腫瘍細胞においてダウンレギュレートされる核酸の使用による、試料の殺腫瘍能を決定するためのプロセス
US20030148920A1 (en) * 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
US20060063230A1 (en) 2000-12-27 2006-03-23 Roman Naworth Sulfatases and methods of use thereof
WO2002074906A2 (fr) * 2001-03-16 2002-09-26 Eli Lilly And Company Proteines de mammiferes lp et reactifs associes
US6461847B1 (en) * 2001-03-19 2002-10-08 Applera Corporation Polynucleotides encoding human estrone sulfatases
US7465553B2 (en) 2001-12-31 2008-12-16 Dana-Farber Cancer Institute, Inc. Psoriasin expression by breast epithelial cells
CA2478850C (fr) 2002-03-13 2018-02-27 Genomic Health, Inc. Profilage d'expression genique dans des tissus tumoraux ponctionnes
CA2527571A1 (fr) * 2003-05-29 2004-12-09 Millennium Pharmaceuticals, Inc. Compositions, kits et procedes d'identification, d'evaluation et de prevention, et therapie anticancereuse
WO2005083440A2 (fr) 2004-02-19 2005-09-09 Yale University Identification de biomarqueurs proteiques du cancer par des techniques proteomiques
MX2007003502A (es) * 2004-09-22 2007-10-10 Tripath Imaging Inc Metodos y productos de programas de computadora para analisis y optimizacion de los candidatos marcadores para el pronostico del cancer.
CA2632419A1 (fr) 2005-12-06 2007-06-14 Kyowa Hakko Kogyo Co., Ltd. Anticorps anti-perp genetiquement recombine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2096417C (fr) * 1991-08-22 2000-10-10 Sarah S. Bacus Methodes et compositions pour le traitement du cancer et pour predire les reactions a la therapie anticancereuse
WO1998018945A1 (fr) * 1996-10-31 1998-05-07 Abbott Laboratories Reactifs et procedes pour le depistage de pathologies mammaires
WO1998034118A1 (fr) * 1997-01-30 1998-08-06 Yale University Methodes diagnostiques et compositions basees sur la repartition de rad51
CA2308029A1 (fr) * 1997-10-31 1999-05-14 Abbott Laboratories Reactifs et procedes utiles pour deceler les pathologies mammaires
JP2001523472A (ja) * 1997-11-18 2001-11-27 アボット・ラボラトリーズ 乳房の疾患の検出に有用な試薬および方法
EP1042360A2 (fr) * 1997-12-24 2000-10-11 Corixa Corporation Composes destines a l'immunotherapie et au diagnostic du cancer du sein, et leur mode d'utilisation
EP1105528A4 (fr) * 1998-08-04 2002-09-04 Diadexus Inc Nouvelle methode permettant de diagnostiquer, de surveiller le cancer du sein, d'en determiner le stade ainsi que d'en former des images et de le traiter

Also Published As

Publication number Publication date
EP1159619A2 (fr) 2001-12-05
WO2000055629A2 (fr) 2000-09-21
WO2000055629A3 (fr) 2001-03-22
AU3752700A (en) 2000-10-04

Similar Documents

Publication Publication Date Title
US20020042067A1 (en) Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
US20020019330A1 (en) Novel methods of diagnosis of angiogenesis, compositions, and methods of screening for angiogenesis modulators
US6750013B2 (en) Methods for detection and diagnosing of breast cancer
CA2368152A1 (fr) Nouvelles techniques permettant de traiter et de diagnostiquer le cancer du sein, compositions et techniques de criblage pour modulateurs de cancer du sein
US6762020B1 (en) Methods of diagnosing breast cancer
JP2006507794A (ja) 癌のための新規の組成物および方法
CA2369319A1 (fr) Methodes permettant de diagnostiquer du cancer colo-rectal, compositions, et methodes permettant de detecter des modulateurs du cancer colo-rectal
US20020015970A1 (en) Novel methods of diagnosis of angiogenesis, compositions, and methods of screening for angiogenesis modulators
US20040259152A1 (en) Novel methods of diagnosing and screening for modulators of tissue remodeling and treating related diseases
US6294343B1 (en) Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
US20030077590A1 (en) Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin
US6455668B1 (en) Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
US20020068036A1 (en) Novel methods of diagnosis of prostate cancer and/or breast cancer, compositions, and methods of screening for prostate cancer and /or breast cancer modulators
US6773878B1 (en) Methods of diagnosing of colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
US6780586B1 (en) Methods of diagnosing breast cancer
US20040009494A1 (en) Novel methods of diagnosis of angiogenesis and other conditions, compositions, and the methods of screening for modulators
US6649342B1 (en) Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
US20030108926A1 (en) Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
US20020076707A1 (en) Novel methods of diagnosing cancer, compositions, and methods of screening for cancer modulators
US6566502B1 (en) Methods of diagnosing cancer, compositions, and methods of screening for cancer modulators
US20030157544A1 (en) Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
WO2002016939A2 (fr) Procedes de diagnostic du cancer, compositions et procedes de depistage de modulateurs du cancer
JP2005531290A (ja) 癌のための新規の組成物および方法
US20030044803A1 (en) Methods for diagnosis and treatment of diseases associated with altered expression of JAK1
US20030198951A1 (en) Novel methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators

Legal Events

Date Code Title Description
FZDE Discontinued
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载